NASCAR will keep drug test details private NASCAR is sticking to its policy of not disclosing the specific substances that cause positive drug tests. Series President Mike Helton said Thursday that even though the rulebook allows series officials to disclose which drugs a competitor has tested positive for, he does not intend to stray from the long-standing policy of keeping those results private. Helton cited federal privacy laws as one reason the series has not publicly said what caused A.J. Allmendinger's positive test. NASCAR has not provided details of the test and has said only that the two urine samples tested positive for the same substance.
Allmendinger was suspended hours before the July 7 race and is now serving an indefinite suspension after his backup "B" sample also tested positive this week. Allmendinger's business manager, Tara Ragan, said the driver tested positive for an amphetamine. Allmendinger has said he did not knowingly ingest a banned substance, and has hired an independent laboratory in an attempt to figure out how he tested positive. But Allmendinger is not fighting the suspension and has instead said he will participate in NASCAR's anti-drug program, which includes an evaluation by a substance abuse professional, along with potential counseling and rehabilitation, so he can be reinstated. More at Associated Press
Copyright 1999-2017 | AutoRacing1 is an
independent internet online publication and is not affiliated with, sponsored by, or endorsed
by IndyCar, NASCAR, FIA, Sprint, or any other series sponsor.
This material may not be published, broadcast, or redistributed without